The battle over drug pricing reforms in the US is heading for the courtroom as multiple pharma companies file legal challenges against the controversial Inflation Reduction Act.
When it comes to marketing digital therapeutics, companies can only do so much on their own until certain information infrastructure is in place, Kristin Milburn, managing director of Healt
The US FDA announced today that it has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio